E-cadherin has also been shown to be upregulated in ovarian cancer (Peralta Soler et al, 1997), renal cell carcinoma (Tani et al, 1995) and breast cancer (Kowalski et al, 2003). Here, CDH1 is linked to ovarian cancer.